Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Specimen Handling 7Cisplatin 7pembrolizumab 6Nivolumab 4Magnetic Resonance Spectroscopy 4Human Papillomavirus DNA Tests 4Fulvestrant 4Colposcopy 4Paclitaxel 3Carboplatin 3Bevacizumab 3palbociclib 2lenvatinib 2Surveys and Questionnaires 2Radiotherapy, Intensity-Modulated 2Radiation Dose Hypofractionation 2Radiation 2Platinum 2Magnetic Resonance Imaging 2Gemcitabine 2Fluorodeoxyglucose F18 2Drug Therapy 2Congresses as Topic 2Brachytherapy 2Biopsy 2Axitinib 23-aminopyridine-2-carboxaldehyde thiosemicarbazone 21,2-diaminocyclohexaneplatinum II citrate 2ulixertinib 1trastuzumab deruxtecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × human papillomavirus vaccine, TA × 30 days × Clear all
NCT06315257 2026-05-20

A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Recruiting
32 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡